Avedro, Inc. Welcomes Robert J. Palmisano To Its Board Of Directors

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Avedro Inc., a Boston-based ophthalmic medical device and pharmaceutical company announces today that Robert J. Palmisano is joining its Board of Directors. Mr. Palmisano is the current President & CEO of Wright Medical Group, Inc. (NASDAQ: WMGI).

Mr. Palmisano has significant experience leading publicly-traded medical device companies, most recently serving as President & CEO of ev3, Inc., a global endovascular device company, from April 2008 to July 2010 when it was acquired by Covidien plc. Prior to ev3, Mr. Palmisano was an instrumental leader in the ophthalmic medical device industry serving as President & CEO of IntraLase Corp. from 2003 to 2007, when it was acquired by AMO and serving as President & CEO of Summit Technology, Inc. from 1997 to 2000 when it was acquired by Alcon, Inc.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC